NEDD4 attenuates phosgene-induced acute lung injury through the inhibition of Notch1 activation.
NEDD4
Notch1
phosgene
pulmonary inflammation
Journal
Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
21
02
2022
received:
26
04
2021
accepted:
04
03
2022
pubmed:
1
4
2022
medline:
18
5
2022
entrez:
31
3
2022
Statut:
ppublish
Résumé
Phosgene gas leakage can cause life-threatening acute lung injury (ALI), which is characterized by inflammation, increased vascular permeability, pulmonary oedema and oxidative stress. Although the downregulation of neuronal precursor cell-expressed developmentally downregulated 4 (NEDD4) is known to be associated with inflammation and oxidative damage, its functions in phosgene-induced ALI remain unclear. In this study, rats with phosgene-induced ALI were intravenously injected with NEDD4-overexpressing lentiviruses to determine the functions of NEDD4 in this inflammatory condition. NEDD4 expression was decreased in the lung parenchyma of phosgene-exposed control rats, whereas its expression level was high in the NEDD4-overexpressing rats. Phosgene exposure increased the wet-to-dry lung weight ratio, but NEDD4 abrogated this effect. NEDD4 overexpression attenuated phosgene-induced lung inflammation, lowering the high lung injury score (based on total protein, inflammatory cells and inflammatory factors in bronchoalveolar lavage fluid) and also reduced phosgene-induced oxidative stress and cell apoptosis. Finally, NEDD4 was found to interact with Notch1, enhancing its ubiquitination and thereby its degradation, thus attenuating the inflammatory responses to ALI. Therefore, we demonstrated that NEDD4 plays a protective role in alleviating phosgene-induced ALI, suggesting that enhancing the effect of NEDD4 may be a new approach for treating phosgene-induced ALI.
Identifiants
pubmed: 35355403
doi: 10.1111/jcmm.17296
pmc: PMC9097839
doi:
Substances chimiques
Notch1 protein, rat
0
Receptor, Notch1
0
Phosgene
117K140075
Nedd4 Ubiquitin Protein Ligases
EC 2.3.2.26
Nedd4 protein, rat
EC 2.3.2.26
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2831-2840Subventions
Organisme : Science and Technology Committee of Jinshan District
ID : 2019-3-07
Organisme : National Natural Science Foundation of China
ID : 82002027
Informations de copyright
© 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Références
Yonsei Med J. 2020 Feb;61(2):186-191
pubmed: 31997628
Cell Death Dis. 2019 Dec 2;10(12):904
pubmed: 31787758
J Cell Mol Med. 2022 May;26(10):2831-2840
pubmed: 35355403
Stem Cell Reports. 2019 May 14;12(5):1041-1055
pubmed: 31056475
Inflammation. 2015;38(3):1281-8
pubmed: 25586485
J Biol Chem. 2015 Oct 2;290(40):24604-13
pubmed: 26296893
Nature. 2014 Mar 13;507(7491):190-4
pubmed: 24499815
Nat Commun. 2020 Apr 24;11(1):2012
pubmed: 32332792
Clin Toxicol (Phila). 2010 Jul;48(6):497-508
pubmed: 20849339
Eur Respir J. 2021 Jan 14;57(1):
pubmed: 32764116
Pharmacol Res. 2016 Jun;108:57-64
pubmed: 27107790
Biol Pharm Bull. 2021 Mar 1;44(3):379-388
pubmed: 33390389
Int J Mol Sci. 2021 Oct 10;22(20):
pubmed: 34681591
Gene. 2015 Feb 25;557(2):113-22
pubmed: 25527121
Inhal Toxicol. 2014 Feb;26(3):185-92
pubmed: 24517841
Med Sci Monit. 2019 Jul 29;25:5621-5629
pubmed: 31354164
Inhal Toxicol. 2013 Apr;25(5):272-9
pubmed: 23614728
Sci Signal. 2008 Sep 23;1(38):ra5
pubmed: 18812566
Toxicol Lett. 2019 Sep 15;312:204-213
pubmed: 31047999
Development. 2017 Mar 1;144(5):866-875
pubmed: 28246214
Ecotoxicol Environ Saf. 2020 Dec 1;205:111283
pubmed: 32977282
Biomed Pharmacother. 2019 Jan;109:1233-1239
pubmed: 30551373
Front Oncol. 2020 Nov 11;10:571914
pubmed: 33262943
Semin Cancer Biol. 2020 Dec;67(Pt 2):92-101
pubmed: 32171886
EBioMedicine. 2016 Aug;10:195-203
pubmed: 27448760
Respir Res. 2012 Mar 30;13:29
pubmed: 22458687
Front Pharmacol. 2020 Dec 11;11:590652
pubmed: 33362546